Singapore markets closed

Genscript Biotech Corporation (1548.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
9.180-0.310 (-3.27%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-95,477
-95,477
-226,851
-358,712
-204,945
-
Depreciation & amortisation
74,046
74,046
64,248
47,779
32,895
-
Stock-based compensation
60,591
60,591
65,154
39,691
17,637
-
Change in working capital
-86,906
-86,906
164,467
142,645
-16,481
-
Inventory
-3,928
-3,928
-19,525
-15,135
-14,965
-
Other working capital
-444,624
-444,624
-323,864
-272,479
-278,840
-
Other non-cash items
-47,565
-47,565
2,183
-1,016
80,828
-
Net cash provided by operating activities
-286,911
-286,911
-120,292
-136,790
-151,093
-
Cash flows from investing activities
Investments in property, plant and equipment
-157,713
-157,713
-203,572
-135,689
-127,747
-
Acquisitions, net
-12,653
-12,653
-1,115
0
-2,067
-
Purchases of investments
-5,743,867
-5,743,867
-988,268
-322,564
-430,727
-
Sales/maturities of investments
5,660,107
5,660,107
766,341
243,980
462,988
-
Other investing activities
-103,844
-103,844
-18,400
1,134
-2,254
-
Net cash used for investing activities
-357,728
-357,728
-443,296
-212,548
-100,166
-
Net change in cash
423,621
423,621
-144,271
552,803
372,944
-
Cash at beginning of period
1,023,999
1,023,999
1,180,971
629,058
252,397
-
Cash at end of period
1,446,403
1,446,403
1,023,999
1,180,971
629,058
-
Free cash flow
Operating cash flow
-286,911
-286,911
-120,292
-136,790
-151,093
-
Capital expenditure
-157,713
-157,713
-203,572
-135,689
-127,747
-
Free cash flow
-444,624
-444,624
-323,864
-272,479
-278,840
-